Back
Ascendis Pharma AS Stock Price Chart

AI Is Changing Marketing Forever-Invest Before the Boom
Invest Now & Secure Your Stake in RAD Intel
Sell
41
ASND
Ascendis Pharma AS
Last Price:
$152.12
Seasonality Move:
-9.72%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.
Ascendis Pharma AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 151.09 | Sell |
20-day SMA: | 146.83 | Buy |
50-day SMA: | 137.67 | Buy |
200-day SMA: | 133.96 | Buy |
8-day EMA: | 149.74 | Buy |
20-day EMA: | 146.54 | Buy |
50-day EMA: | 140.27 | Buy |
200-day EMA: | 133.94 | Buy |
Ascendis Pharma AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.37 | Buy |
Relative Strength Index (14 RSI): | 55.48 | Buy |
Chaikin Money Flow: | 369780 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.82 - 155.92) | Buy |
Bollinger Bands (100): | (124.33 - 143.13) | Buy |
Ascendis Pharma AS Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ascendis Pharma AS Stock
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 150.31 while ASND 8-day simple moving average is 151.09, which is a Sell signal.
-
The stock price of ASND is 150.31 while Ascendis Pharma AS 20-day SMA is 146.83, which makes it a Buy.
-
Ascendis Pharma AS 50-day simple moving average is 137.67 while ASND share price is 150.31, making it a Buy technically.
-
ASND stock price is 150.31 and Ascendis Pharma AS 200-day simple moving average is 133.96, creating a Buy signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy or a Sell?
-
Ascendis Pharma AS stock is rated a SellThe current Ascendis Pharma AS [ASND] share price is $150.31. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma AS Stock Info
Market Cap:
9B
Price in USD:
150.31
Share Volume:
465.9K
Ascendis Pharma AS 52-Week Range
52-Week High:
158.00
52-Week Low:
111.09
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Ascendis Pharma AS Share Price Forecast
-
What is the Ascendis Pharma AS stock price today?The Ascendis Pharma AS stock price is 150.31 USD today.
-
Will ASND stock go up or go down?Ascendis Pharma AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Ascendis Pharma AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma AS is overvalued.
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 150.31 while ASND 8-day exponential moving average is 149.74, which is a Buy signal.
-
The stock price of ASND is 150.31 while Ascendis Pharma AS 20-day EMA is 146.54, which makes it a Buy.
-
Ascendis Pharma AS 50-day exponential moving average is 140.27 while ASND share price is 150.31, making it a Buy technically.
-
ASND stock price is 150.31 and Ascendis Pharma AS 200-day simple moving average is 133.94, creating a Buy signal.
Fundamental Analysis of Ascendis Pharma AS
Is Ascendis Pharma AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.17 per share, an increase this year of $3.03 per share, and an increase next year of $5.43 per share.
Technical Analysis of Ascendis Pharma AS
Should I short Ascendis Pharma AS stock?
-
ASND Moving Average Covergence Divergence (MACD) indicator is 4.37, suggesting Ascendis Pharma AS is a Buy
-
Ascendis Pharma AS Relative Strength Index (RSI) is 55.48, which suggest Ascendis Pharma AS is overbought
-
The Bollinger Bands (25) for Ascendis Pharma AS is (128.82 - 155.92), which suggest Ascendis Pharma AS is a Buy
-
The Bollinger Bands (100) for Ascendis Pharma AS is (124.33 - 143.13), which suggest Ascendis Pharma AS is a Buy
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.